Products
Platform
Research
Market
Learn
Sun Pharmaceutical Industries Ltd Financials Statements
Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios
Consolidate
Standalone
Total Qtr Revenue cr | 14,948.23 | 14,315.86 | 13,571.71 | 14,141.08 | 13,645.39 |
| Other Income Qtr Cr | 469.92 | 464.46 | 612.87 | 465.62 | 354.00 |
| Operating Revenues Qtr | 14,478.31 | 13,851.40 | 12,958.84 | 13,675.46 | 13,291.39 |
Loading chart... | |||||
Operating Expenses Qtr | 9,951.26 | 9,549.74 | 9,242.75 | 9,666.44 | 9,352.43 |
Operating Profit Qtr | 4,527.05 | 4,301.66 | 3,716.09 | 4,009.02 | 3,938.96 |
EBITDA Qtr Cr | 4,996.97 | 3,948.12 | 3,967.28 | 4,158.47 | 4,292.96 |
Depreciation Qtr | 729.50 | 700.55 | 663.79 | 630.56 | 625.91 |
Net Profit Qtr | 3,117.95 | 2,278.63 | 2,149.88 | 2,903.38 | 3,040.16 |
Basic EPS Qtr | 13.00 | 9.50 | 9.00 | 12.10 | 12.70 |
Open Demat Account
Open Demat Account